Innospec Inc (IOSP)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash and cash equivalents US$ in thousands 289,200 303,800 240,200 270,100 203,700 207,200 165,900 147,500 147,100 100,500 71,400 105,600 141,800 89,200 94,400 117,000 105,300 66,600 58,200 68,100
Short-term investments US$ in thousands
Total current liabilities US$ in thousands 371,400 373,100 332,800 364,900 371,500 344,200 364,900 381,600 405,800 381,400 369,200 352,300 336,600 308,300 291,000 274,300 252,400 229,800 219,200 266,100
Cash ratio 0.78 0.81 0.72 0.74 0.55 0.60 0.45 0.39 0.36 0.26 0.19 0.30 0.42 0.29 0.32 0.43 0.42 0.29 0.27 0.26

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($289,200K + $—K) ÷ $371,400K
= 0.78

The cash ratio of Innospec Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The ratio started at 0.26 on March 31, 2020, and gradually increased to 0.43 on March 31, 2021. There was a slight dip to 0.32 on June 30, 2021, followed by fluctuating values until reaching 0.55 on December 31, 2023.

From March 31, 2024, to December 31, 2024, there was a significant increase in the cash ratio from 0.74 to 0.78. This indicates that Innospec Inc had more liquid assets available to cover its current liabilities by the end of 2024. Overall, the cash ratio trend suggests that the company has been gradually improving its ability to meet its short-term obligations using its cash and cash equivalents.